# RheoFit

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rheofit

- Industry: Medical Devices & Equipment
- Headquarters: Hong Kong, Hong Kong SAR - China
- Website: www.rheofit.com.cn
- Latest round: Angel (Oct 9, 2024)
- Investors on record: 3

## About

Based in Hong Kong and founded in 2023, Yunwang Innovation Intelligence (Shenzhen) Co., Ltd., trading as RheoFit, is a developer of rehabilitation and physical therapy products, dedicated to combining rehabilitation medicine theory, intelligent technology, and industrial design concepts to create more scientific, effective, and user-friendly rehabilitation products, helping sports enthusiasts easily achieve deep muscle and fascia relaxation. In December 2025, RheoFit raised a pre-series A+ funding from new investor Monolith Management.
The company specializes in developing advanced therapeutic products, with a primary focus on the RheoFit A1, the world's first intelligent rolling massage device launched in 2023. This innovative product is designed to alleviate fatigue and muscle soreness, functioning as a personal rehabilitation tool. The RheoFit A1 utilizes AI-driven customization to create tailored massage experiences based on individual body models, addressing specific recovery needs for various physical activities, including running, cycling, hiking, and swimming. The device is marketed toward sports enthusiasts and health-conscious individuals, having reached customers in over 20 countries and regions, including markets in Asia, Europe, and North America. By enhancing muscle recovery and providing an efficient relaxation experience, RheoFit positions its offerings to meet the growing demand for effective wellness solutions.
The company's revenue structure is anchored in direct-to-consumer sales of its flagship product, the RheoFit A1, which is available through its official website and potentially through partnerships with health and wellness retailers. The company employs a straightforward transaction model whereby customers purchase the device outright, ensuring a one-time revenue stream per unit sold. 
The Pre-series A+ round of funding will be used to accelerate product development and market expansion.

## Funding rounds

- Angel, Oct 9, 2024 — Green Pine Capital Partners, Qianhai Kekong Lingdingyang Venture Capital, Yuewan Huasheng Capital

## Investors

- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Angel
- Qianhai Kekong Lingdingyang Venture Capital (https://capitalatlas.ai/funds/qianhai-kekong-lingdingyang-venture-capital) — Angel
- Yuewan Huasheng Capital (https://capitalatlas.ai/funds/yuewan-huasheng-capital) — Angel